Extended-release Antiepilepsy Drugs— Review of the Effects of Once-daily Dosing on Tolerability, Effectiveness, Adherence, Quality of Life, and Patient Preference

Share Article

US Neurology, the Peer-reviewed Journal, Publish Cutting-edge Article by Basim M. Uthman On Extended-release Antiepilepsy Drugs— Review of the Effects of Once-daily Dosing On Tolerability, Effectiveness, Adherence, Quality of Life, and Patient Preference

News Image
Poor adherence to therapy is associated with a number of negative consequences, including an increase in patient seizures and mortality.

US Neurology, the Peer-reviewed Journal, Publish Cutting-edge Article by Basim M. Uthman On Extended-release Antiepilepsy Drugs— Review of the Effects of Once-daily Dosing On Tolerability, Effectiveness, Adherence, Quality of Life, and Patient Preference.

Long-term adherence to antiepilepsy drug (AED) regimens is frequently suboptimal. Poor adherence to therapy is associated with a number of negative consequences, including an increase in patient seizures and mortality. Non-adherence is related to a variety of factors, such as treatment-related adverse events, convenience of treatment, efficacy, and quality of life. There is therefore a need for treatment strategies in epilepsy that improve long-term adherence. One such strategy is the use of extended-release (ER) AED formulations. Advantages of ER AEDs over other AED formulations include the potential for once-daily dosing, a more stable mean drug concentration over time, improved tolerability profiles, maximal use of the therapeutic window, and the possibility to achieve better seizure control. Improvements in overall treatment effectiveness may therefore increase patient adherence. This review presents evidence related to patient adherence and preference patterns for ER AEDs and highlights the beneficial properties of ER AEDs.

To continue reading this peer-reviewed article in full for free, please go to: http://www.touchneurology.com/articles/extended-release-antiepilepsy-drugs-review-effects-once-daily-dosing-tolerability-effective.

NOTE TO EDITORS:
touchNEUROLOGY (a division of Touch Medical Media) provides independent, cutting-edge, peer-reviewed content from world renowned physicians, designed to lead the debate on health and to engage, inform, and support physicians in improving patient outcomes globally.

touchNEUROLOGY.com provides an international platform for peer-reviewed content from industry-leading journals alongside other carefully selected sources and aims to support physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity within the field of neurology.

Our portfolio of peer-reviewed journals, European Neurological Review and US Neurology comprise of concise review articles which are designed to keep busy physicians up-to-date with the latest developments in their field and serve as a key reference resource for the international neurology community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Barney Kent
@touchNEUROLOGY
Follow >
Touch Medical Media

Visit website